Prospective multicenter study of the impact of the 21-gene recurrence score (RS) assay on medical oncologist (MO) and patient (pt) adjuvant breast cancer (BC) treatment selection

被引：0
|
作者：
Lo, S. S.
Norton, J.
Mumby, P. B.
Smerage, J.
Kash, J.
Chew, H. K.
Hayes, D.
Epstein, A.
Albain, K. S.
机构：
[1] Loyola Univ, Maywood, IL 60153 USA
[2] Univ Michigan, Ann Arbor, MI 48109 USA
[3] Edward Hosp, Naperville, IL USA
[4] Univ Calif Davis, Sacramento, CA 95817 USA
[5] Mt Sinai Med Ctr, New York, NY 10029 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
577
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Prospective Multicenter Study of the Impact of the 21-Gene Recurrence Score Assay on Medical Oncologist and Patient Adjuvant Breast Cancer Treatment Selection
    Lo, Shelly S.
    Mumby, Patricia B.
    Norton, John
    Rychlik, Karen
    Smerage, Jeffrey
    Kash, Joseph
    Chew, Helen K.
    Gaynor, Ellen R.
    Hayes, Daniel F.
    Epstein, Andrew
    Albain, Kathy S.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (10) : 1671 - 1676
  • [2] Extended follow-up results from a prospective multi-center study of the impact of the 21-gene recurrence score assay on medical oncologist and patient adjuvant breast cancer treatment selection, satisfaction, and anxiety
    Lo, S. S.
    Mumby, P. B.
    Rychlik, K.
    Smerage, J.
    Kash, J.
    Chew, H. K.
    Hayes, D.
    Albain, K. S.
    CANCER RESEARCH, 2009, 69 (02) : 235S - 235S
  • [3] Obesity at diagnosis and breast cancer (BC) recurrence risk based on the 21-gene assay recurrence score (RS).
    Ridolfi, Kimberly
    Zhang, Chong
    Onitilo, Adedayo A.
    Ledesma, Wendy M.
    Andreason, Molly
    Engel, Jessica Marie
    Kim, KyungMann
    Wisinski, Kari Braun
    Tevaarwerk, Amye
    Charlson, John A.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [4] Prospective multi-center study of the impact of the 21-gene recurrence score assay on patient satisfaction, anxiety arid decisional conflict for adjuvant breast cancer treatment selection
    Mumby, P. B.
    Lo, S. S.
    Norton, J.
    Smerage, J.
    Joseph, K.
    Chew, H. K.
    Hayes, D.
    Albain, K. S.
    BREAST CANCER RESEARCH AND TREATMENT, 2007, 106 : S73 - S74
  • [5] Surgeon and medical oncologist peer network effects on the uptake of the 21-gene breast cancer recurrence score assay
    Zipkin, Ronnie
    Schaefer, Andrew
    Chamberlin, Mary
    Onega, Tracy
    O'Malley, Alistair J.
    Moen, Erika L.
    CANCER MEDICINE, 2021, 10 (04): : 1253 - 1263
  • [6] First prospective multicenter Italian study on the impact of the 21-gene recurrence score (RS) in adjuvant clinical decisions for ER1/HER2-early breast cancer (BC) patients
    Dieci, M. V.
    Guarneri, V.
    Giarratano, T.
    Mion, M.
    Tortora, G.
    Morandi, P.
    Gori, S.
    Merlini, L.
    Oliani, C.
    Pasini, F.
    Bonciarelli, G.
    Griguolo, G.
    Orvieto, E.
    Del Bianco, P.
    De Salvo, G. L.
    Conte, P.
    ANNALS OF ONCOLOGY, 2017, 28
  • [7] First prospective multicenter Italian study on the impact of the 21-Gene Recurrence Score (RS) in adjuvant clinical decisions for ER+/HER2-early breast cancer (BC) patients.
    Dieci, Maria Vittoria
    Guarneri, Valentina
    Giarratano, Tommaso
    Mion, Marta
    Tortora, Giampaolo
    Morandi, Paolo
    Gori, Stefania
    Merlini, Laura
    Oliani, Cristina
    Pasini, Felice
    Bonciarelli, Giorgio
    Griguolo, Gaia
    Orvieto, Enrico
    Del Bianco, Paola
    De Salvo, Gian Luca
    Conte, Pier Franco
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [8] First prospective multicenter Italian study on the impact of the 21-gene recurrence score® (RS) in adjuvant clinical decisions for ER +/HER2-early breast cancer patients
    Dieci, M. V.
    Guarneri, V.
    Mion, M.
    Tortora, G.
    Morandi, P.
    Gori, S.
    Merlini, L.
    Oliani, C.
    Pasini, F.
    Bonciarelli, G.
    Orvieto, E.
    Del Bianco, P.
    De Salvo, G. L.
    Conte, P. F.
    ANNALS OF ONCOLOGY, 2016, 27
  • [9] Prospective Evaluation of the Impact of the 21-Gene Recurrence Score Assay on Adjuvant Treatment Decisions for Women with Node-Positive Breast Cancer in Ontario, Canada
    Torres, Sofia
    Trudeau, Maureen
    Gandhi, Sonal
    Warner, Ellen
    Verma, Sunil
    Pritchard, Kathleen I.
    Petrella, Teresa
    Hew-Shue, Mark
    Chao, Calvin
    Eisen, Andrea
    ONCOLOGIST, 2018, 23 (07): : 768 - 775
  • [10] Prospective evaluation of the impact of the 21-gene recurrence score® assay on adjuvant treatment decisions for women with node-positive breast cancer in Ontario, Canada
    Torres, S.
    Trudeau, M.
    Gandhi, S.
    Warner, E.
    Verma, S.
    Pritchard, K.
    Petrella, T.
    Slodkowska, E.
    Hew-Shue, M.
    Chao, C.
    Eisen, A.
    ANNALS OF ONCOLOGY, 2016, 27
12345